We're continuing our gastrointestinal journey with hepatitis and cirrhosis - conditions representing the spectrum from acute liver inflammation to chronic scarring and dysfunction. I'll guide you through the various causes of hepatitis, the progression to cirrhosis, and the complex management of end-stage liver disease. Understanding this continuum is crucial as liver disease affects millions worldwide and requires a comprehensive approach to prevention, diagnosis, and treatment. Let's explore the remarkable liver and what happens when it's under attack!
🩺 Hepatitis: Overview and Classification
Hepatitis refers to inflammation of the liver, which can be acute (self-limited) or chronic (persisting >6 months). The causes are diverse, with viral hepatitis being most common.
Acute Hepatitis
- Duration: <6 months
- Common causes: Viral (A-E), drugs, toxins
- Presentation: Jaundice, malaise, nausea
- Most cases resolve completely
- Small percentage progress to acute liver failure
Chronic Hepatitis
- Duration: >6 months
- Common causes: HBV, HCV, autoimmune, metabolic
- Presentation: Often asymptomatic until advanced
- Can progress to cirrhosis, liver cancer
- Requires ongoing monitoring and treatment
| Type | Transmission | Chronicity Risk | Prevention | Treatment |
|---|---|---|---|---|
| Hepatitis A | Fecal-oral | None (acute only) | Vaccine, hygiene | Supportive care |
| Hepatitis B | Blood, sexual, perinatal | 5-10% (adults), 90% (neonates) | Vaccine, safe practices | Antivirals (tenofovir, entecavir) |
| Hepatitis C | Blood, rare sexual | 75-85% | No vaccine, safe practices | Direct-acting antivirals (cure >95%) |
| Hepatitis D | Blood, requires HBV coinfection | 70-90% | HBV vaccination | Interferon, new agents emerging |
| Hepatitis E | Fecal-oral (waterborne) | Rare (except immunocompromised) | Clean water, vaccine available in some countries | Supportive care, ribavirin in severe cases |
🔄 Pathophysiology of Liver Injury
Liver injury progresses through stages from inflammation to fibrosis and eventually cirrhosis. Understanding this progression helps in staging and prognosis.
Inflammation Phase
- Hepatocyte injury and death
- Immune cell infiltration
- Cytokine release
- Elevated transaminases
- Potentially reversible
Fibrosis Phase
- Activation of hepatic stellate cells
- Collagen deposition
- Extracellular matrix accumulation
- Architectural distortion
- Potentially reversible with treatment
Cirrhosis Phase
- Bridging fibrosis
- Regenerative nodules
- Vascular reorganization
- Portal hypertension
- Generally irreversible
👨⚕️ Clinical Presentation
Liver disease presentations range from asymptomatic biochemical abnormalities to florid liver failure. Recognizing patterns helps in diagnosis and urgency of intervention.
Acute Hepatitis Features
Constitutional Symptoms
- Malaise, fatigue
- Nausea, vomiting
- Anorexia, weight loss
- Fever (especially viral)
- Arthralgias, rash (especially HBV)
Hepatobiliary Symptoms
- Right upper quadrant pain
- Jaundice
- Dark urine
- Pale stools
- Pruritus (cholestatic)
Cirrhosis and Decompensation
| Complication | Pathophysiology | Clinical Features | Management |
|---|---|---|---|
| Ascites | Portal hypertension, low albumin, sodium retention | Abdominal distension, fluid wave, shifting dullness | Salt restriction, diuretics, paracentesis |
| Variceal Bleeding | Portal hypertension → collateral vessels | Hematemesis, melena, shock | Resuscitation, band ligation, TIPS |
| Hepatic Encephalopathy | Gut-derived toxins bypass liver → brain | Confusion, asterixis, coma | Lactulose, rifaximin, protein restriction |
| Hepatorenal Syndrome | Renal vasoconstriction, systemic vasodilation | Oliguria, rising creatinine | Volume expansion, vasoconstrictors, liver transplant |
| Spontaneous Bacterial Peritonitis | Translocation of gut bacteria | Fever, abdominal pain, worsening ascites | Antibiotics, albumin, SBP prophylaxis |
🔍 Diagnostic Approach
Liver disease evaluation involves blood tests to assess function and injury, imaging to evaluate structure, and sometimes liver biopsy for definitive diagnosis.
Liver Biochemical Tests
| Test Category | Key Tests | Pattern Interpretation | Clinical Significance |
|---|---|---|---|
| Hepatocellular Injury | ALT, AST | ALT > AST (viral), AST > ALT (alcoholic) | Degree of hepatocyte damage |
| Cholestasis | ALP, GGT, bilirubin | Elevated ALP out of proportion to transaminases | Biliary obstruction or injury |
| Liver Synthetic Function | Albumin, PT/INR | Low albumin, prolonged INR | Severity of liver dysfunction |
| Portal Hypertension | Platelet count | Thrombocytopenia | Hypersplenism from portal HTN |
Diagnostic Modalities
Non-invasive Tests
- Ultrasound: First-line imaging, detects fat, nodules, ascites
- Elastography (FibroScan): Measures liver stiffness
- Serum biomarkers: APRI, FIB-4, ELF score
- CT/MRI: Detailed anatomy, vascular assessment
Invasive Tests
- Liver biopsy: Gold standard for fibrosis staging
- HVPG measurement: Direct portal pressure measurement
- Endoscopy: Varices screening and treatment
💊 Management Strategies
Management depends on the specific liver disease, stage of fibrosis, and presence of complications. Treatment ranges from specific therapies to supportive care.
Specific Therapies
| Condition | First-line Therapy | Alternative Options | Monitoring |
|---|---|---|---|
| Chronic HBV | Tenofovir or Entecavir | Peginterferon, TAF | ALT, HBV DNA, HBsAg, HCC screening |
| Chronic HCV | Direct-acting antivirals (8-12 weeks) | Various combinations based on genotype | SVR12 (cure test), HCC screening if cirrhotic |
| Autoimmune Hepatitis | Prednisone + Azathioprine | Mycophenolate, budesonide | ALT, IgG, liver biopsy for remission |
| Alcoholic Hepatitis | Alcohol cessation, nutrition | Prednisolone (severe cases), pentoxifylline | Maddrey's discriminant function, Lille score |
| NASH/NAFLD | Weight loss, exercise | Vitamin E, pioglitazone, GLP-1 agonists | Serial elastography, metabolic parameters |
Cirrhosis Complications Management
Ascites Management
- Salt restriction (<2g/day)
- Diuretics: Spironolactone ± Furosemide
- Large-volume paracentesis with albumin
- TIPS for refractory cases
- Liver transplant evaluation
Variceal Bleeding Prevention
- Non-selective beta-blockers (propranolol, nadolol)
- Endoscopic variceal ligation
- Antibiotic prophylaxis (norfloxacin)
- Avoid NSAIDs, alcohol
⚠️ Special Considerations
Certain liver conditions require specific diagnostic approaches and management strategies due to their unique pathophysiology.
Alcoholic Liver Disease
- Spectrum: Steatosis → hepatitis → cirrhosis
- AST:ALT ratio typically >2:1
- GGT often markedly elevated
- Macrocytosis even without anemia
- Abstinence is cornerstone of management
NAFLD/NASH
- Hepatic manifestation of metabolic syndrome
- Most common liver disease in developed countries
- Diagnosis of exclusion
- Weight loss of 7-10% improves histology
- Can progress to cirrhosis and HCC
🌱 Prevention and Prognosis
Liver disease prevention and early detection are crucial given the silent nature of many conditions until advanced stages.
Primary Prevention
- Vaccination (Hep A, Hep B)
- Safe injection practices
- Alcohol moderation/abstinence
- Healthy weight maintenance
- Medication safety awareness
Secondary Prevention
- Universal HCV screening (CDC recommendation)
- Targeted HBV screening (high-risk groups)
- Regular monitoring of known liver disease
- HCC surveillance in high-risk patients
Prognostic Scoring
- Child-Pugh score: A, B, C classification
- MELD score: For transplant prioritization
- Maddrey's DF: Alcoholic hepatitis prognosis
- King's College criteria: Acute liver failure
🧠 Key Takeaways
- Hepatitis can be acute or chronic, with viral causes being most common
- Progression: Inflammation → fibrosis → cirrhosis → decompensation
- Viral hepatitis B and C are major causes of chronic liver disease worldwide
- Cirrhosis complications include ascites, variceal bleeding, and encephalopathy
- Diagnosis involves blood tests, imaging, and sometimes liver biopsy
- Treatment includes specific therapies (antivirals) and complication management
- Prevention through vaccination and lifestyle modifications is crucial
- Liver transplant is definitive treatment for end-stage liver disease
🧭 Conclusion
We've explored the comprehensive landscape of hepatitis and cirrhosis, student—from acute viral infections to the complex management of end-stage liver disease. Remember that many liver conditions are silent until advanced stages, making screening and early detection crucial. I encourage you to master the interpretation of liver biochemical patterns and understand the principles of cirrhosis management. Excellent work building your hepatology knowledge! Next, we'll examine inflammatory bowel disease and its challenging diagnostic and therapeutic aspects.
In liver disease management, preventing progression is as important as treating complications - early intervention can change the natural history.